Cargando…
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models
PURPOSE: Abnormalities within the Sonic Hedgehog (SHH), Bone Morphogenetic Protein (BMP) and SMAD4 signalling pathways have been associated with the malignant behavior of esophageal adenocarcinoma (EAC). We recently developed two specific llama-derived antibodies (VHHs), C4C4 and C8C8, which target...
Autores principales: | Li, Shulin, Hoefnagel, Sanne J. M., Read, Matthew, Meijer, Sybren, van Berge Henegouwen, Mark I., Gisbertz, Suzanne S., Bonora, Elena, Liu, David S. H., Phillips, Wayne A., Calpe, Silvia, Correia, Ana C. P., Sancho-Serra, Maria D. C., Mattioli, Sandro, Krishnadath, Kausilia K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333053/ https://www.ncbi.nlm.nih.gov/pubmed/35902550 http://dx.doi.org/10.1007/s13402-022-00689-2 |
Ejemplares similares
-
Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors
por: Calpe, Silvia, et al.
Publicado: (2016) -
Detection of circulating BMP5 as a risk factor for Barrett’s esophagus
por: Correia, Ana C. P., et al.
Publicado: (2020) -
Single domain Camelid antibody fragments for molecular imaging and therapy of cancer
por: Li, Shulin, et al.
Publicado: (2023) -
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma
por: Li, Shulin, et al.
Publicado: (2023) -
Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies
por: Hoefnagel, Sanne J. M., et al.
Publicado: (2022)